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in a human immunodeficiency virus (HIV)-negative 
patient. The patient was successfully treated with no 
recurrence, after intact surgical removal, mitomycin 
C (MMC) treatment, and cryotherapy.
CASE REPORT
A 38-year-old female patient, a farmer by occupation, 
presented to the OPD with complaints of foreign body 
sensation, redness, and diminution of vision in the right 
eye since 1 year. She also noticed a mass in the right 
eye, which gradually increased in size [Figure 1]. There 
was no history of trauma or foreign body in the right 
eye and no history of any ocular surgery in the past.
There was no history of weight loss. Systemic 
examination revealed no abnormality. Ocular 
examination revealed a 12 mm × 11 mm spherical mass 
all over the cornea. The mass was grayish, white, and 
INTRODUCTION
Ocular surface squamous neoplasia (OSSN) is 
uncommon with an incidence of 0.13–1.9/100,000 
population, and it primarily occurs in older 
males.[1,2] OSSN includes dysplastic lesions involving 
the squamous epithelium of the conjunctiva 
or cornea, which includes squamous papilloma, 
conjunctival‑cornea intraepithelial neoplasia, 
carcinoma in situ (CIS), and invasive squamous cell 
carcinoma (SCC). Epibulbar SCC and epithelioma 
have been noted commonly, but cases in which the 
tumor is primary on the cornea are sufficiently rare to 
warrant reporting in each instance. We describe a rare 
case of noninvasive OSSN involving the entire cornea 
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the cornea are sufficiently rare to warrant reporting in 
each instance.
OSSN is often diagnosed in the early stages due to the 
easily visible location. OSSN involves the conjunctiva 
granular. It appeared to be adherent to the underlying 
cornea. Almost entire cornea was covered, only a rim 
of the cornea was visible nasally. The mass was limited 
only to the cornea. The details of the anterior chamber, 
iris, pupil, and lens could not be visualized. The visual 
acuity of the right eye was the only perception of light 
and projection of rays in all the quadrants. Intraocular 
pressure was digitally normal. Ocular movements were 
full and free in all directions of gaze. The left eye was 
normal in all aspects. Preauricular and submandibular 
lymph nodes were not palpable. The patient was not 
positive for HIV. Clinical diagnosis of OSSN of the 
cornea was made. The patient was posted for a surgical 
excision of the mass.
A disposable plastic drape was sutured around the 
limbus over the surrounding conjunctiva so that only 
the cornea was exposed. This was done to prevent 
seedling. Whole corneal mass was dissected out with 
lamellar dissection of superficial cornea using a crescent 
blade. The mass was excised in toto, along the surgical 
plane, so the extent was well demarcated. The excised 
mass was sent for histopathological examination. The 
histopathological report confirmed the existence of SCC 
of the cornea [Figure 2]. Double freeze-thaw cryotherapy 
was applied with conical probe of 1 mm, to cover the entire 
peripheral cornea. Postoperative treatment included 
topical application of steroid‑antibiotic combination 
and atropine 1% eye drop 3 times a day. The eye was 
patched for a week till complete epithelialization of 
the cornea took place. Punctal occlusion was achieved 
with punctal plugs before starting mitomycin therapy. 
MMC eye drop (0.02%) was advised 4 times a day 
after the completion of epithelialization, with 1 week 
on and 1 week off, in alternating cycles for 8 weeks. 
The best corrected visual acuity recovered to 6/18. The 
patient did not show any signs of recurrence during the 
follow-up period of 1 year [Figure 3].
DISCUSSION
OSSN is uncommon and it primarily occurs in 
older males (78.5%). The average age of occurrence 
has been noted to be 60 years, ranging from 20 
to 88 years.[3] A number of risk factors, including 
genetic predisposition, fair skin, pale irises, high 
propensity to sunburn, a past history of skin cancer, 
immunosuppression, human papillomavirus (HPV) 
infection, chronic infection by HPV, HIV, or trachoma, 
vitamin A deficiency, xeroderma pigmentosum, and 
smoking, have been associated with the appearance 
of OSSN. It is estimated that the risk of SCC increases 
13-fold in patients with HIV.[4] The disease behaves in 
a much more aggressive manner in patients with AIDS. 
Epibulbar SCC and epithelioma have been noted 
commonly, but cases in which the tumor is primary on 
Figure 1: Preoperative clinical photograph of the entire corneal 
involvement of squamous cell carcinoma
Figure 2: Histopathological slide confirming the diagnosis of 
squamous cell carcinoma
Figure 3: Postoperative clinical photograph of the eye free from 
squamous cell carcinoma
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very effective. This is typically accomplished through 
topical eye drops of MMC, 5-fluorouracil, or interferon 
alpha 2B. MMC appears to produce cell death in 
OSSN by apoptosis and necrosis.[9] MMC is used in the 
concentration of 0.02–0.04% 4 times a day, with 1-week 
on and 1-week off, in alternating cycles for a maximum 
of 8 weeks. The 1-week on, 1-week off regimen prevents 
damage to more slowly dividing epithelial cells and 
limbal stem cells, allowing them to repair their DNA. 
Allowing time for complete epithelial healing before 
application of MMC is important in avoiding the most 
serious complications such as corneal epitheliopathy, 
scleral ulceration, uveitis, cataract, and glaucoma. Side 
effects from topical chemotherapy include dry eye, 
superficial punctate epitheliopathy, punctal stenosis, 
and rarely stem cell deficiency. Punctal occlusion with 
punctal plugs is recommended before starting these 
regimens to prevent punctal stenosis.[5,7,8]
In this case, whole corneal mass was dissected out 
with lamellar dissection of superficial cornea using a 
crescent blade. Double freeze-thaw cryotherapy was 
applied with a conical probe of 1 mm, to cover the entire 
peripheral cornea. MMC eye drop (0.02%) was advised 
4 times a day after the completion of epithelialization, 
with 1 week on and 1 week off, in alternating cycles for 
8 weeks. The peculiar points of this case are, the patient 
was HIV negative; the whole cornea was involved 
which could be removed intact successfully.
Squamous lesions of the cornea and conjunctiva 
are uncommon, but early diagnosis and initiation 
of treatment are key in prevention of visual loss and 
systemic morbidity and mortality. Our patient recovered 
well with no recurrence because of prompt treatment 
with complete excision followed by chemotherapy.
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or the cornea individually but more commonly 
involves both. The clinical presentation of these lesions 
varies across a wide spectrum and can range from 
mild to severe dysplasia to full‑thickness epithelial 
dysplasia (CIS) and invasive SCC. OSSN typically 
presents as a growth on the ocular surface and gives rise 
to symptoms such as foreign body sensation, redness or 
irritation and rarely, diminution of vision due to high 
astigmatism or involvement of visual axis. Over 95% 
of OSSN cases originate in the limbus, often in the 
interpalpebral region.[5,6] The reason for the propensity 
of the lesions to this region is thought to be due to a 
combination of factors, including the presence of 
transitional type epithelium, high ultraviolet exposure, 
and a high mitotic rate.[5]
Masses are initially mobile; the conjunctiva in later 
stages becoming fixed to the globe with deeper scleral 
infiltration. Through close, careful examination 
with slit lamp biomicroscopy, OSSN lesions can 
frequently be distinguished from other conjunctival 
lesions, such as pterygia and conjunctival lymphoma. 
The gold standard for the diagnosis of OSSN is the 
histopathological evaluation of the lesion after an 
incisional or excisional biopsy.
It is not unusual for invasive SCC to invade locally 
into the sclera, intraocularly, or into the orbit, with one 
study, estimating incidence rates to be 37%, 13%, and 
11%, respectively.[7]
The line of management mainly depends on the type 
of lesion and histopathologic findings, and can range 
from topical chemotherapy or excision alone for 
smaller lesions to a combination of surgical excision, 
cryotherapy, and chemotherapy for larger or invasive 
lesions. Rarely, radiotherapy, and in extreme cases, 
enucleation and even exenteration, may be required.[5,7,8]
Dissection of all abnormal tissue with a wide surgical 
conjunctival margin of 3 mm is usually sufficient. 
Intraoperative cryotherapy is commonly used as 
adjunctive therapy as it is known to decrease the 
recurrence rate by the destruction of any residual 
tumor tissue beyond the horizontal or deep surgical 
margin of the wound. If the lesion extends onto the 
cornea, absolute alcohol can be used to remove the 
involved corneal epithelium. Copious irrigation needs 
to be performed following the application of absolute 
alcohol. After removal of larger tumors, conjunctival 
autografts or amniotic membrane grafts can be used to 
help close the conjunctival defect.[5,8]
Chemotherapy has become the mainstay of adjunctive 
treatment with surgical excision and has shown to be 
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